The DOI matches its Crossref record; 101 of the 102 references it cites were found in a registry or an index.
Cancer and the chemokine network
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CXCL1 and 2 are 90% identical by amino-acid sequence and signal through the same receptor CXCR2 (Balkwill, 2004).”
From A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis (2012) · cites this paper as Balkwill, 2004
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Self-citationInternational Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,923
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1256 · Cited by 3,413
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Käkönen, S.-M., Cordon‐Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,605
Flagged first, then by citations
1 of the 102 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Darash-Yahana, M. et al. Human prostate cancer growth, vascularisation and metastasis is stimulated via high expression levels of the chemokine receptor CXCR4. Proc. Am. Assoc. Cancer Res. 44, 789 (2003).
Cited by
Sorted by citations
Items 501–600 of 1,000
Nerves and Pancreatic Cancer: New Insights into A Dangerous Relationship
Gasparini, G., Pellegatta, M., Crippa, S., Lena, M. S., Belfiori, G., Doglioni, C., Taveggia, C., & Falconi, M. (2019) · Cancers · doi:10.3390/cancers11070893 · Cited by 92
Zhang, J., Patel, L. R., & Pienta, K. J. (2010) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385071-3.00003-4 · Cited by 95
Role of the nervous system in cancer metastasis
Li, S., Sun, Y., & GAO, D. (2013) · Oncology Letters · doi:10.3892/ol.2013.1168 · Cited by 94
Tissue microenvironment dictates the fate and tumor-suppressive function of type 3 ILCs
Nussbaum, K., Burkhard, S., Ohs, I., Mair, F., Klose, C. S. N., Arnold, S. J., Diefenbach, A., Tugues, S., & Becher, B. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20162031 · Cited by 98
Yang, J., Kumar, A., Vilgelm, A. E., Chen, S., Ayers, G. D., Novitskiy, S. V., Joyce, S., & Richmond, A. J. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0045 · Cited by 96
Xu-Monette, Z. Y., Tu, M., Jabbar, K. J., Cao, X., Tzankov, A., Visco, C., Cai, Q., Montes‐Moreno, S., An, Y., Dybkær, K., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3479 · Cited by 96
Gatla, H. R., Muniraj, N., Thevkar, P., Yavvari, S., Sukhavasi, S., & Makena, M. R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051110 · Cited by 91
Zeng, Q., Sun, S., Li, Y., Li, X., Li, Z., & Liang, H. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01555 · Cited by 90
Tumor-Associated Macrophages in Gliomas—Basic Insights and Treatment Opportunities
Andersen, J. K., Miletić, H., & Hossain, J. A. (2022) · Cancers · doi:10.3390/cancers14051319 · Cited by 94
Prevention of Colitis-Associated Carcinogenesis with Infliximab
Kim, Y. J., Hong, K. S., Chung, J. W., Kim, J. H., & Hahm, K. B. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0272 · Cited by 91
Zhou, W., Du, M., Dong, L., Yu, J. M., & Li, D.-J. (2008) · Human Reproduction · doi:10.1093/humrep/den308 · Cited by 90
Chemokines in tumor development and progression
Mukaida, N., & Baba, T. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.10.012 · Cited by 92
Honoki, K. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1220 · Cited by 90
Dual‐Function CXCR4 Antagonist Polyplexes To Deliver Gene Therapy and Inhibit Cancer Cell Invasion
Li, J., Zhu, Y. T., Hazeldine, S. T., Li, C., & Oupický, D. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203463 · Cited by 90
Wu, L., Du, H., Li, Y., Qu, P., & Yan, C. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.06.028 · Cited by 89
Li, H., Wang, K., Yang, X., Zhou, Y., Ping, Q., Oupický, D., & Sun, M. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.01.070 · Cited by 88
Targeting IL-8 in colorectal cancer
Ning, Y., & Lenz, H. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.677440 · Cited by 89
Zhang, J., Sarkar, S., & Yong, V. W. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi183 · Cited by 92
Hsu, M., Wu, S.-Y., Chang, S.-S., Su, I., Tsai, C.-H. A., Lai, S.-J., Shiau, A., Takada, K., & Chang, Y. (2008) · Journal of Virology · doi:10.1128/jvi.02301-07 · Cited by 89
Zhang, T., Somasundaram, R., Berencsi, K., Caputo, L., Gimotty, P. A., Rani, P., Guerry, D., Swoboda, R., & Herlyn, D. (2006) · European Journal of Immunology · doi:10.1002/eji.200526208 · Cited by 89
Multi-faceted strategies to combat disease by interference with the chemokine system
Johnson, Z., Schwarz, M. K., Power, C., Wells, T. N. C., & Proudfoot, A. E. I. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.03.001 · Cited by 89
NLRC4 suppresses melanoma tumor progression independently of inflammasome activation
Janowski, A. M., Colegio, O. R., Hornick, E. E., McNiff, J. M., Martin, M. D., Badovinac, V. P., Norian, L. A., Zhang, W., Cassel, S. L., & Sutterwala, F. S. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86953 · Cited by 94
Neutrophil‐Based Delivery Systems for Nanotherapeutics
Han, Y., Zhao, R., & Xu, F. (2018) · Small · doi:10.1002/smll.201801674 · Cited by 89
Adipose tissue-derived progenitor cells and cancer
Zhang, Y. (2010) · World Journal of Stem Cells · doi:10.4252/wjsc.v2.i5.103 · Cited by 87
Zhou, F., Wang, P., Peng, Y., Zhang, P., Huang, Q., Sun, W., He, N., Fu, T., Zhao, Z., Fang, X., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201903807 · Cited by 87
Role of immunotherapy in Ewing sarcoma
Morales, E., Olson, M., Cardenas, F. I., Dahiya, S., Luetkens, T., & Atanackovic, D. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000653 · Cited by 87
Salogni, L., Musso, T., Bosisio, D., Mirolo, M., Jala, V. R., Haribabu, B., Locati, M., & Sozzani, S. (2009) · Blood · doi:10.1182/blood-2008-12-194597 · Cited by 87
Murakami, T., Sato, A., Chun, N. A. L., Hara, M., Naito, Y., Kobayashi, Y., Kano, Y., Ohtsuki, M., Furukawa, Y., & Kobayashi, E. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701216 · Cited by 87
Kogan-Sakin, I., Cohen, M., Paland, N., Madar, S., Solomon, H., Molchadsky, A., Brosh, R., Buganim, Y., Goldfinger, N., Klocker, H., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp043 · Cited by 87
Puxeddu, E., Knauf, J. A., Sartor, M. A., Mitsutake, N., Smith, E. P., Medvedovic, M., Tomlinson, C. R., Moretti, S., & Fagin, J. A. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00947 · Cited by 87
Bridge, J. A., Lee, J., DAUD, A. I., Wells, J. W., & Bluestone, J. A. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00351 · Cited by 86
Bugide, S., Gupta, R., Green, M. R., & Wajapeyee, N. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2102718118 · Cited by 86
Chamseddine, A. N., Assi, T., Mir, O., & Chouaïb, S. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107986 · Cited by 89
Tumor microenvironment and immunotherapy for triple-negative breast cancer
Guo, Z., Zhu, Z., Lin, X., Wang, S., Wen, Y., Wang, L., Zhi, L., & Zhou, J. (2024) · Biomarker Research · doi:10.1186/s40364-024-00714-6 · Cited by 95
CXCL17 Expression by Tumor Cells Recruits CD11b+Gr1highF4/80− Cells and Promotes Tumor Progression
Matsui, A., Yokoo, H., Negishi, Y., Endo‐Takahashi, Y., Chun, N. A. L., Kadouchi, I., Suzuki, R., Maruyama, K., Aramaki, Y., Semba, K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044080 · Cited by 86
Jeng, J.-S., Tsai, J., Chuang, L.-Y., Ho, M., Lin, Z., Hsieh, M., Chen, S.-C., Chuang, W., Wang, L., Yu, M., et al. (2007) · Neoplasia · doi:10.1593/neo.07781 · Cited by 88
Cell communication networks in cancer invasion
Calvo, F., & Sahai, E. A. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2011.04.010 · Cited by 89
Yamanaka, T., Matsumoto, S., Teramukai, S., Ishiwata, R., Nagai, Y., & Fukushima, M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603831 · Cited by 86
CD4+CXCR4highCD69+ T Cells Accumulate in Lung Adenocarcinoma
Wald, O., Izhar, U., Amir, G., Avniel, S., Bar-Shavit, Y., Wald, H., Weiss, I. D., Galun, E., & Peled, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.6983 · Cited by 86
Linking inflammation to tumorigenesis in a mouse model of high-fat-diet-enhanced colon cancer
Day, S. D., Enos, R. T., McClellan, J. L., Steiner, J. L., Velázquez, K. T., & Murphy, E. A. (2013) · Cytokine · doi:10.1016/j.cyto.2013.04.031 · Cited by 85
Chemokine Decoy Receptor D6 Plays a Negative Role in Human Breast Cancer
Wu, F.-Y., Ou, Z.-L., Feng, L.-Y., Luo, J.-M., Wang, L.-P., Shen, Z., & Shao, Z.-M. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2108 · Cited by 85
Blair, A. B., Kim, V. M., Muth, S. T., Saung, M. T., Lokker, N. A., Blouw, B., Armstrong, T. D., Jaffee, E. M., Tsujikawa, T., Coussens, L. M., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-4192 · Cited by 87
Gupta, R., Malvi, P., Parajuli, K. R., Janoštiak, R., Bugide, S., Cai, G., Zhu, L. J., Green, M. R., & Wajapeyee, N. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005156117 · Cited by 85
Molecular and Biological Mechanisms of Bone Metastasis
Cecchini, M. G., Wetterwald, A., van der Pluijm, G., & Thalmann, G. N. (2005) · EAU Update Series · doi:10.1016/j.euus.2005.09.006 · Cited by 89
The chemokine network: A target in cancer biology?
Slettenaar, V. I. F., & Wilson, J. L. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.03.012 · Cited by 87
Cancer models in Caenorhabditis elegans
Kirienko, N. V., Mani, K., & Fay, D. S. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22247 · Cited by 87
Kenig, S., Alonso, M. B. D., Mueller, M. M., & Lah, T. T. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.07.014 · Cited by 84
Silva, J. D. A. P., Trindade, E. B. S. D. M., Fabre, M. E. D. S., Menegotto, V. M., Gevaerd, S. R., Buss, Z. D. S., & Fröde, T. S. (2012) · Nutrition and Cancer · doi:10.1080/01635581.2012.643133 · Cited by 85
van der Sluis, T. C., Sluijter, M., van Duikeren, S., West, B. L., Melief, C. J. M., Arens, R., van der Burg, S. H., & van Hall, T. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0052 · Cited by 84
Lopez‐Bergami, P., & Barbero, G. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09878-7 · Cited by 84
The Signaling Duo CXCL12 and CXCR4: Chemokine Fuel for Breast Cancer Tumorigenesis
Zielińska, K. A., & Katanaev, V. L. (2020) · Cancers · doi:10.3390/cancers12103071 · Cited by 85
Chemokines and glioma: Invasion and more
Sciumè, G., Santoni, A., & Bernardini, G. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.019 · Cited by 84
Rusek, A. M., Abba, M. L., Eljaszewicz, A., Moniuszko, M., Nikliński, J., & Allgayer, H. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0302-8 · Cited by 81
Li, H., Yang, X., Zhou, Z., Wang, K., Li, C., Qiao, H., Oupický, D., & Sun, M. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.06.029 · Cited by 83
Macrophages in tumor: An inflammatory perspective
Goswami, K. K., Bose, A., & Baral, R. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108875 · Cited by 88
Xia, J., Zhang, S., Zhang, R., Wang, A., Zhu, Y., Dong, M., Ma, S., Hong, C., Liu, S., Wang, D., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01623-2 · Cited by 89
Zhu, G., Yan, H. H., Pang, Y., Jiang, J., Achyut, B. R., Liang, X., Weiss, J. M., Wiltrout, R. H., Hollander, M. C., & Yang, H. H. (2015) · Oncotarget · doi:10.18632/oncotarget.6125 · Cited by 83
Imaging agents for the chemokine receptor 4 (CXCR4)
Kuil, J., Buckle, T., & van Leeuwen, F. W. B. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35085h · Cited by 83
Development of novel CXCR4-based therapeutics
Peled, A., Wald, O., & Burger, J. A. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.656197 · Cited by 83
Ren, H., Yu, D., Ge, B., Cook, B., Xu, Z., & Zhang, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004509 · Cited by 84
The good and bad faces of the CXCR4 chemokine receptor
Teixidó, J., Martínez‐Moreno, M., Díaz‐Martínez, M., & Sevilla‐Movilla, S. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.12.018 · Cited by 92
Yuan, X., Nie, W., He, Z., Yang, H. J., Shao, B., Ma, X., Zhang, X., Bi, Z., Sun, L., Liang, X., et al. (2020) · Theranostics · doi:10.7150/thno.34065 · Cited by 82
Inflammatory mediators of uveitis: cytokines and chemokines
Curnow, J., & Murray, P. I. (2006) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e32801094b5 · Cited by 82
Role of chemokine receptor CXCR7 in bladder cancer progression
Hao, M., Zheng, J., 侯恺林, Wang, J., Chen, X., Lu, X., 卜, 军., Xu, C., Shen, K., & Wang, J. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.04.007 · Cited by 82
CXCR7 stimulates MAPK signaling to regulate hepatocellular carcinoma progression
Lin, L., Mm, H., Wang, F., Ll, X., Hx, Y., & Py, Y. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.392 · Cited by 82
Bartolomé, R. A., Ferreiro, S., Miquilena-Colina, M. E., Martínez‐Prats, L., Soto‐Montenegro, M. L., García‐Bernal, D., Vaquero, J. J., Agami, R., Delgado, R. B., Desco, M., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080636 · Cited by 82
Chan, O., Burke, J. D., Gao, D. F., & Fish, E. N. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.348946 · Cited by 86
The Chemokine (CCL2–CCR2) Signaling Axis Mediates Perineural Invasion
He, S., He, S., Chen, C., Deborde, S., Bakst, R. L., Chernichenko, N., McNamara, W. F., Lee, S. Y., Barajas, F., Yu, Z., et al. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0303 · Cited by 81
Zhang, S., Qi, L., Li, M., Zhang, D., Xu, S., Wang, N., & Sun, B. (2008) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-27-62 · Cited by 82
Chemokines in human colorectal carcinoma.
Baier, P. K., Eggstein, S., Wolff-Vorbeck, G., Baumgartner, U., & Hopt, U. T. (2005) · PubMed · Cited by 81
Biomarker discovery for renal cancer stem cells
Corrò, C., & Moch, H. (2017) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.91 · Cited by 84
Cytokine CCL5 and receptor CCR5 axis in glioblastoma multiforme
Kranjc, M. K., Novak, M., Pestell, R. G., & Lah, T. T. (2019) · Radiology and Oncology · doi:10.2478/raon-2019-0057 · Cited by 81
Fujihara, A., Kurooka, M., Miki, T., & Kaneda, Y. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0351-y · Cited by 81
Taccioli, C., Chen, H., Jiang, Y., Liu, X., Huang, K., Smalley, K. J., Farber, J. L., Croce, C. M., & Fong, L. Y. Y. (2011) · Oncogene · doi:10.1038/onc.2011.592 · Cited by 81
No common denominator for breast cancer lymph node metastasis
Weigelt, B., Wessels, L. F. A., Bosma, A. J., Glas, A. M., Nuyten, D. S. A., He, Y. D., Dai, H., Peterse, J. L., & Veer, L. J. V. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602794 · Cited by 81
Snyder, E. L., Saenz, C. C., Denicourt, C., Meade, B. R., Cui, X.-S., Kaplan, I. M., & Dowdy, S. F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0118 · Cited by 84
Duan, F., Qian, F., Fang, K., Lin, K., Wang, W., & Chen, Y. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-164 · Cited by 82
Netanely, D., Avraham, A., Ben‐Baruch, A., Evron, E., & Ron Shamir, A. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0724-2 · Cited by 77
Indicators of responsiveness to immune checkpoint inhibitors
Shields, B. D., Mahmoud, F. A., Taylor, E. M., Byrum, S. D., Sengupta, D., Koss, B. S., Baldini, G., Ransom, S. C., Cline, K., Mackintosh, S. G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01000-2 · Cited by 81
Liu, Y., Liu, L., Zhou, Y., Zhou, P., Yan, Q., Chen, X., Ding, S., & Zhu, F. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3510 · Cited by 80
Groves, M. D., Hess, K. R., Puduvalli, V. K., Colman, H., Conrad, C. A., Gilbert, M. R., Weinberg, J. S., Cristofanilli, M., Yung, W. K. A., & Liu, T. J. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9819-2 · Cited by 80
Cabıoğlu, N., Şahin, A. A., Morandi, P., Meric‐Bernstam, F., Islam, R., Lin, H. Y., Bucana, C. D., Gonzalez-Angulo, A. M., Hortobágyi, G. N., & Cristofanilli, M. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn740 · Cited by 80
Divergent Routes to Oral Cancer
Hunter, K. D., Thurlow, J. K., Fleming, J., Drake, P. J. H., Vass, J. K., Kalna, G., Higham, D. J., Herzyk, P., MacDonald, D. G., Parkinson, E. K., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0186 · Cited by 82
Zhao, S., Wang, J., & Qin, C. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-014-0103-8 · Cited by 80
Tumor-Associated Macrophage: Its Role in Cancer Invasion and Metastasis
Shih, J.-Y., Yuan, A., Chen, J. J., & Yang, P. (2006) · doi:10.29685/jcm.200606.0001 · Cited by 80
Sjöberg, E., Augsten, M., Bergh, J. C. S., Jirström, K., & Östman, A. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.104 · Cited by 80
Individual Cell-Based Models of Tumor-Environment Interactions
Galle, J., Sittig, D., Hanisch, I., Wobus, M., Wandel, E., Loeffler, M., & Aust, G. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060006 · Cited by 83
Delayed Wound Healing and Epidermal Hyperproliferation in Mice Lacking JunB in the Skin
Florin, L., Knebel, J., Zigrino, P., Vonderstrass, B., Mauch, C., Schorpp-Kistner, M., Szabowski, A., & Angel, P. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700123 · Cited by 79
Lin, S., Zhang, X., Huang, G., Cheng, L., Lv, J., Zheng, D., Lin, S., Wang, S., Wu, Q., Long, Y., et al. (2021) · Oncogene · doi:10.1038/s41388-020-01605-4 · Cited by 81
Price, G. A., Bouras, A., Hambardzumyan, D., & Hadjipanayis, C. G. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103453 · Cited by 79
de Haan, L., Suijker, J., van Roey, R., Berges, N., Petrova, E. P., Queiroz, K. C. S., Strijker, W., Olivier, T., Poeschke, O., Garg, S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158234 · Cited by 79
Deutsch, A. J. A., Steinbauer, E., Hofmann, N., Strunk, D., Gerlza, T., Beham‐Schmid, C., Schaider, H., & Neumeister, P. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.134 · Cited by 78
Tissue Microenvironment Modulates CXCR4 Expression and Tumor Metastasis in Neuroblastoma
Zhang, L., Yeger, H., Das, B., Irwin, M. S., & Baruchel, S. (2007) · Neoplasia · doi:10.1593/neo.06670 · Cited by 80
Molecular Pathogenesis of MALT Lymphoma
Troppan, K. T., Wenzl, K., Neumeister, P., & Deutsch, A. J. A. (2015) · Gastroenterology Research and Practice · doi:10.1155/2015/102656 · Cited by 83
Atypical chemokine receptors in cancer: friends or foes?
Massara, M., Bonavita, O., Mantovani, A., Locati, M., & Bonecchi, R. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3mr0915-431rr · Cited by 79
Yasuoka, H., Tsujimoto, M., Yoshidome, K., Nakahara, M., Kodama, R., Sanke, T., & Nakamura, Y. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-340 · Cited by 78
Zhu, F., Li, X., Chen, S., Zeng, Q., Zhao, Y., & Luo, F. (2016) · Medical Oncology · doi:10.1007/s12032-016-0729-9 · Cited by 76
Multifaceted role of chemokines in solid tumors: From biology to therapy
Raza, S., Rajak, S., Tewari, A., Gupta, P., Chattopadhyay, N., Sinha, R. A., & Chakravarti, B. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.12.011 · Cited by 79
Chen, J., Xu-Monette, Z. Y., Deng, L., Shen, Q., Manyam, G. C., Martínez-López, A., Zhang, L., Montes‐Moreno, S., Visco, C., Tzankov, A., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3343 · Cited by 77
Jung, J. I., Cho, H., Jung, Y. J., Kwon, S., Her, S., Choi, S. S., Shin, S., Lee, K. W., & Park, J. H. Y. (2014) · International Journal of Cancer · doi:10.1002/ijc.28983 · Cited by 81
Metadata
- Authors
- Balkwill, F.
- Venue
- Nature Reviews Cancer
- Published
- 2004-07
- Volume
- 4
- Issue
- 7
- Pages
- 540-550
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1986986419
- Cited by
- 2,343
- References
- 102
- Citations by year
- 2026: 31 · 2025: 45 · 2024: 57 · 2023: 82 · 2022: 112 · 2021: 132 · 2020: 122 · 2019: 84 · 2018: 131 · 2017: 127 · 2016: 134 · 2015: 133 · 2014: 152 · 2013: 119 · 2012: 135
- FWCI
- 9.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- chemokines, chemokine receptors, carcinogenesis, metastasis, tumor-host interaction, metastatic potential, site-specific metastasis, chemokine receptor antagonists, inflammation, autoimmune disease, cancer therapy
- MeSH terms
- Animals, Antineoplastic Agents, Autoimmune Diseases, Chemotaxis, Leukocyte, Humans, Inflammation, Macrophage Activation, Mice, Nude, Models, Biological, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasm Proteins, Neoplasms, Lymphocytes, Tumor-Infiltrating, Chemokines, Receptors, Chemokine, Xenograft Model Antitumor Assays, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review